NCT03390504 2026-04-13THORJanssen Research & Development, LLCPhase 3 Active not recruiting629 enrolled 32 charts 1 FDA
NCT04656652 2026-03-24Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01)Daiichi SankyoPhase 3 Active not recruiting605 enrolled 14 charts 3 FDA